CN1036973C - Nerve block injection - Google Patents
Nerve block injection Download PDFInfo
- Publication number
- CN1036973C CN1036973C CN93118189A CN93118189A CN1036973C CN 1036973 C CN1036973 C CN 1036973C CN 93118189 A CN93118189 A CN 93118189A CN 93118189 A CN93118189 A CN 93118189A CN 1036973 C CN1036973 C CN 1036973C
- Authority
- CN
- China
- Prior art keywords
- vitamin
- milligrams
- injection
- nerve
- examples
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Expired - Fee Related
Links
Landscapes
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Abstract
The present invention provides nerve blocking injecting liquid used for treating the obstinate diseases of lumbar disc protrusion, etc., which is made by the mixing preparation of triamcinolone diacetate-A, vitamin B, vitamin B2, dexamethasone, 2% of lidocaine, 3% of ephedrine and physiological saline. The injecting injection made by the nerve blocking injecting liquid is in accordance with the medical sanitary standard, and has the advantages of no toxic or side effect, safety, high curing rate and simple and feasible method. Meanwhile, the nerve blocking injecting liquid has obvious treating effects on soft tissue and muscle damage, orthopedics department diseases and peripheral nerve damage diseases by nerve, channel and acupoint injection. The analysis of the clinical treating effect of 3860 instances in a plurality of hospitals shows that the effective rate is 100%, and the curing rate is higher than 90%.
Description
The present invention relates to a kind of neural analgesic injection, this injection mainly is suitable for treating prolapse of lumbar intervertebral disc.
At present, commonly encountered diseases, many sick diseases that all belongs to nervous lesion as diseases such as prolapse of lumbar intervertebral disc, cervical spondylosis, scapulohumeral periarthritis, hyperplastic spondylitis and sciatica.These diseases all are the diseases of difficult smelting, and it has a strong impact on patient's life and work.The method for the treatment of above-mentioned disease in recent years is more, for example adopt methods such as operation, traction, massage, manual reduction, physical therapy and medicine penetrate treatment prolapse of lumbar intervertebral disc, but effect is all undesirable.Especially operative treatment is bigger to the human body destructiveness, because furcella is cut off, waist joint stability is affected, and recurrence easily, and the patient is reluctant to accept.
Existing documents 1 " day English-Chinese medicine dictionary " (Tianjin science tech publishing house), in December, 1992,89th, 107,118,232 and the 453-454 page or leaf in, and documents 2 " new pharmacology " (People's Health Publisher), in December, 1985,286th, 395,500, in 524-525,526-527 and the 560-561 page or leaf, to lignocaine, ephedrine, vitamin B
12, dexamethasone, Triamcinolone Acetonide, vitamin B
1Medicinal property detailed description is all arranged.Above-mentioned dexamethasone and Triamcinolone Acetonide (claiming triamcinolone acetonide acetate again) are mainly used in antiinflammatory; Vitamin B
1And vitamin B
12Be mainly used in trophic nerve; Lignocaine is mainly used in local anesthesia; Ephedrine is mainly used in the disease of treatment respiratory system aspect.Introduce according to documents 1 and documents 2, above-mentioned each single medicine all can not be used for the treatment of prolapse of lumbar intervertebral disc separately.
The purpose of this invention is to provide a kind of neural analgesic injection, this injection is suitable for treating persistent ailments such as prolapse of lumbar intervertebral disc, to overcome the shortcoming in the above-mentioned existing Therapeutic Method.
Neural analgesic injection provided by the present invention by the checking of the clinical practice more than 4 years, is the desirable medicinal liquid of present non-operative treatment prolapse of lumbar intervertebral disc.This medicinal liquid is all effective in cure to the disease of soft tissue and muscle injury, orthopaedic disease and peripheral lesion simultaneously.
According to the characteristics of prolapse of lumbar intervertebral disc is outthrust compressing exciting nerve root, produces inflammatory edema, makes patient's lumbago and with the radioactivity lower limb pain.The main effect of neural analgesic injection provided by the present invention is analgesia spasmolytic, antiinflammatory, detumescence, relaxing muscles and tendons to promote blood circulation, expelling wind and cold, microcirculation improvement, accelerate effluxing of metabolite, inflammation district injured nerve there is direct effect, help the reparation of neurocyte, suppress effects such as hyperosteogeny and rheumatism disease.
Observe by hospital clinical before 406 hospitals of the Chinese People's Liberation Army, 403 hospitals, tiger beach, Dalian orthopaedics hospital, the mountain range, Dalian, some cases is done the CT scan contrast before and after treatment, the prolapse of lumbar intervertebral disc thing obviously diminishes or disappears, because medicine directly acts on, make the dissolved absorption of prolapse of lumbar intervertebral disc thing part and also receive, the compressing of nerve root is stimulated freed and reach the healing purpose.
Neural analgesic injection of the present invention is by Triamcinolone Acetonide, vitamin B
1, vitamin B
12, dexamethasone, 2% lignocaine, 3% ephedrine and normal saline mixed preparing form, and wherein prepares in 1500 milliliters of injection, its each components contents is:
Triamcinolone Acetonide 500-2500 milligram
Vitamin B
1The 5000-10000 milligram
Vitamin B
12The 25-50 milligram
Dexamethasone 500-1000 milligram
2% lignocaine 500-1000 milliliter
3% ephedrine 200-500 milligram
The normal saline surplus.
The said medicine mixed dissolution is shaken up, and autoclaving promptly can be used for the patient then.
According to the state of an illness, the component content in this prescription can suitably be adjusted, and specific embodiment is as follows:
Embodiment 1: with 600 milligrams of Triamcinolone Acetonides, vitamin B
16000 milligrams, vitamin B
1230 milligrams, 600 milligrams of dexamethasone, 500 milligrams of containers of putting into 2000 milliliters of 3% ephedrine, and then add 700 milliliters normal saline, shake up dissolving, add 800 milliliters of 2% lignocaine again, shake up the opaque mixed liquor of pinkiness, be divided in 15 milliliters the peace bottle, amount to 100, promptly can be used for the patient behind the autoclaving.
Embodiment 2: 1500 milligrams of Triamcinolone Acetonides, vitamin B
18000 milligrams, vitamin B
1225 milligrams, 500 milligrams of dexamethasone, 250 milligrams of 3% ephedrine, 1000 milliliters of normal saline, 500 milliliters of 2% lignocaine, method is the same, shakes up the opaque mixed liquor of pinkiness.
Lignocaine in the neural analgesic injection of the present invention plays the pain relieving effect; Vitamin B
1And vitamin B
12Drug effect be trophic nerve, play the neural effect of repairing; The inflammation that dexamethasone and Triamcinolone Acetonide cause a variety of causes has tangible nonspecific inhibitory action, can make the vasoconstriction of inflammation part, capillary permeability reduces, ooze out, hyperemia, swelling alleviate or disappear, can suppress fibroblast proliferation and granulation tissue to the inflammation later stage generates, the reduce inflammation adhesion and the cicatrization at position reduce sequela, thus play antiinflammatory, desensitize, enhance metabolism, the effect of microcirculation improvement; Ephedrine plays the effect of eliminating nervous edema.Said medicine is mixed together with physiology saline and separates the opaque mixed liquor of pinkiness deeply.Each component has not only been brought into play the effect of single medicine separately in the medicinal liquid that mixes, and main is to combine the combination acts synergistically of having brought into play medicine, has brought into play the length of each component drug, keeps away the weak point of its each component drug, has produced a kind of new medical application.
The usage of neural analgesic injection of the present invention is that medicinal liquid of the present invention is directly injected the prolapse of lumbar intervertebral disc position by the epidural space conduit, carry out Drug therapy, also can adopt neural meridians, acupoint injection therapy on every side, make the nerve root that stimulates that suffers oppression in time obtain pain relieving, antiinflammatory, detumescence, desensitize and free, the impaired nerve in inflammation district there are direct nutrition and repair, help the recovery of neural and cell.
Medicinal liquid of the present invention is through four tame hospitals, 3860 routine clinical curative effect analysis, and effective percentage reaches 100%, and cure rate reaches more than 90%, have no side effect and sequela, and safe and feasible, patient's no pain is easily accepted short treating period.Especially adopting the injection of neural meridian point on every side, is the desirable medicinal liquid of present non-operative treatment prolapse of lumbar intervertebral disc.
Observe summary by hospital clinical before 406 hospitals of the Chinese People's Liberation Army, 403 hospitals and tiger beach, Dalian orthopaedics hospital and the mountain range, Dalian, with injection for treating prolapse of lumbar intervertebral disc 2000 examples of the present invention, male's 1540 examples wherein, women's 460 examples, age was from 20 to 70 years old, the course of disease is the shortest 1 year, (wherein 80% patient accepted treatments such as massage, traction, manual reduction, physical therapy and medicine penetrate in the longest 20 years, DeGrain), 5 healing person's 832 examples, 10 healing person's 1520 examples, 15 healing person's 354 examples, 33 examples take a turn for the better.Total effective rate 100%, cure rate 98.3%.
Cervical spondylosis 361 examples, 3 healing person's 82 examples, 6 healing 23 examples, 9 healing 48 examples, 8 examples that take a turn for the better, cure rate 98.6%.
Hyperplastic spondylitis 434 examples, 3 healing 56 examples, 6 healing 14 examples, 9 healing 20 examples, 12 examples that take a turn for the better, cure rate 92.1%.
Old articular degeneration 215 examples, 3 healing person's 43 examples, 6 healing person's 131 examples, 9 healing person's 34 examples, 7 examples that take a turn for the better, cure rate 96.7%.
Scorching 123 examples of the exudative synovial bursa film of knee joint, 3 healing person's 26 examples, 6 healing person's 97 examples, cure rate 100%.
Claims (3)
1. a neural analgesic injection is characterized in that it is by Triamcinolone Acetonide, vitamin B
1, vitamin B
12, dexamethasone, 2% lignocaine, 3% ephedrine and normal saline mixed preparing form, and wherein prepares in 1500 milliliters of injection, its each components contents is:
Triamcinolone Acetonide 500-2500 milligram
Vitamin B
1The 5000-10000 milligram
Vitamin B
12The 25-50 milligram
Dexamethasone 500-1000 milligram
2% lignocaine 500-1000 milliliter
3% ephedrine 700-500 milligram
The normal saline surplus.
2. injection as claimed in claim 1 is characterized in that described each constituent content is:
600 milligrams of Triamcinolone Acetonides
Vitamin B
16000 milligrams
Vitamin B
1230 milligrams
600 milligrams of dexamethasone
800 milliliters of 2% lignocaine
500 milligrams of 3% ephedrine
The normal saline surplus.
3. injection as claimed in claim 1 is characterized in that described each constituent content is:
1500 milligrams of Triamcinolone Acetonides
Vitamin B
18000 milligrams
Vitamin B
1225 milligrams
500 milligrams of dexamethasone
500 milliliters of 2% lignocaine
250 milligrams of 3% ephedrine
The normal saline surplus.
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN93118189A CN1036973C (en) | 1993-10-14 | 1993-10-14 | Nerve block injection |
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN93118189A CN1036973C (en) | 1993-10-14 | 1993-10-14 | Nerve block injection |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| CN1096676A CN1096676A (en) | 1994-12-28 |
| CN1036973C true CN1036973C (en) | 1998-01-14 |
Family
ID=4992373
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| CN93118189A Expired - Fee Related CN1036973C (en) | 1993-10-14 | 1993-10-14 | Nerve block injection |
Country Status (1)
| Country | Link |
|---|---|
| CN (1) | CN1036973C (en) |
Families Citing this family (4)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN1322896C (en) * | 2005-03-31 | 2007-06-27 | 田哲 | Acupuncture point injection mixture for treating mastopathy proliferation, its preparation method and application |
| CN106177926A (en) * | 2016-08-31 | 2016-12-07 | 孟凡珍 | A kind of epidural dropping liquid treats the medicine of chronic lumbago and skelalgia |
| CN106176866A (en) * | 2016-08-31 | 2016-12-07 | 孟凡珍 | Local injection treats the medicine of chronic neck, shoulder, waist and leg arthralgia |
| WO2024051847A1 (en) * | 2022-09-09 | 2024-03-14 | 北京达尔文细胞生物科技有限公司 | Pharmaceutical composition for preventing and treating facial nerve micro-entrapment syndrome and use thereof |
-
1993
- 1993-10-14 CN CN93118189A patent/CN1036973C/en not_active Expired - Fee Related
Non-Patent Citations (1)
| Title |
|---|
| 中国《日英汉药物词典》 天津科技出版社 * |
Also Published As
| Publication number | Publication date |
|---|---|
| CN1096676A (en) | 1994-12-28 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| US5817699A (en) | Process for the preparation of ketamine ointment | |
| Razzano et al. | Noninvasive interactive neurostimulation therapy for the treatment of low-grade lateral ankle sprain in the professional contact sport athlete improves the short-term recovery and return to sport: a randomized controlled trial | |
| CN1036973C (en) | Nerve block injection | |
| CN101322786B (en) | External-use medicament for treating bone fracture and traumatic injury | |
| CN102600256B (en) | Traditional Chinese medical composition for treatment of traumatic injury | |
| CN101843801B (en) | Bone permeable blood-activating and pain-relieving tincture | |
| Hardy | Chronic pain management: the essentials | |
| Brosseau et al. | Efficacy of transcutaneous electrical nerve stimulation for osteoarthritis of the lower extremities: a meta-analysis | |
| CN103565969A (en) | Traditional Chinese medicine composition for treating soft tissue injury and fracture | |
| Wal et al. | A Wholistic Approach to Non-Pharmacological Intervention for Primary Dysmenorrhea | |
| Zhao et al. | Ultrasound-guided continuous femoral nerve block with dexmedetomidine combined with low concentrations of ropivacaine for postoperative analgesia in elderly knee arthroplasty | |
| CN102274372B (en) | Traditional Chinese medicine for treating traumatic fracture rheumatism and various types of hemorrhage | |
| CN100361679C (en) | Medicine of yellow cinnamon root for activating collaterals | |
| CN109289020A (en) | Chinese medicine acupoint magnetic heat orients transdermal | |
| CN108686146A (en) | A kind of Dressed plaster promoting blood circulation and removing blood stasis and preparation method thereof | |
| RU2787805C1 (en) | Method for the treatment of gonarthrosis | |
| Mishra et al. | Exploring the Science of Marma-An Ancient Healing Technique-Part 4: Marma Therapy | |
| CN112220835A (en) | External liniment for treating rheumatism | |
| Anantkumar et al. | Ayurveda approaches towards the management of sport injury wsr to sport medicine | |
| Shaji et al. | A REVIEW ON AYURVEDIC PERSPECTIVE OF SPORTS INJURIES AND ITS MANAGEMENT | |
| CN100352477C (en) | Wound healing medicine | |
| CN106109965A (en) | A kind of Chinese medicine composition treating flaccidity disease | |
| CN1094354C (en) | Nafiverine injection | |
| Chitlange et al. | Comprehensive Rehabilitation of Charcot Foot With Equinovarus Deformity: A Case Report | |
| Mishra et al. | Exploring the Science of Marma-An Ancient Healing Technique: Marma Therapy |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| C06 | Publication | ||
| PB01 | Publication | ||
| C10 | Entry into substantive examination | ||
| SE01 | Entry into force of request for substantive examination | ||
| C14 | Grant of patent or utility model | ||
| GR01 | Patent grant | ||
| C19 | Lapse of patent right due to non-payment of the annual fee | ||
| CF01 | Termination of patent right due to non-payment of annual fee |